Interventional, Open-label Trial, Investigating the Effectiveness of Eptinezumab in Participants With Migraine and Previous Inadequate Response to CGRP-targeting Therapies
This study is testing a medication called eptinezumab to see if it helps reduce migraines and improve quality of life. It is especially designed for people who have tried other similar migraine prevention treatments without success.
You might be able to join if you have had migraines for at least a year, experience 8 or more migraine days a month, and have tried a previous prevention medication that did not work well enough for you.
Participants will receive the study medication through an IV infusion to help prevent migraines. Throughout the study, your symptoms and overall well-being will be closely monitored by the research team.
This study has trial locations in places like Phoenix, Arizona, and Little Rock, Arkansas. The study has already been completed.
- 1Tests the medication eptinezumab for migraine prevention
- 2For adults whose previous migraine treatments did not work
- 3Medication is given through an IV
Related links
Outside pages about this study, checked by our team
This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.